Mir-30a Inhibits Osteolysis by Targeting Runx2 in Giant Cell Tumor of Bone

Quan Huang,Zhengyu Jiang,Tong Meng,Huabin Yin,Jing Wang,Wei Wan,Mo Cheng,Wangjun Yan,Tielong Liu,Dianwen Song,Haiyan Chen,Zhipeng Wu,Wei Xu,Zhenxi Li,Wang Zhou,Jianru Xiao
DOI: https://doi.org/10.1016/j.bbrc.2014.09.076
IF: 3.1
2014-01-01
Biochemical and Biophysical Research Communications
Abstract:RunX2 has been identified to crucially regulate the osteolysis in giant cell tumor of bone. MiR-30a is an intronic miRNA identified as tumor suppressor, but little is known about its role in giant tumor cell of bone. In our research, we reported miR-30a was down-regulated in GCT whereas RunX2 was highly expressed. Further research proved that miR-30a can regulate the expression of RunX2 by binding to its 3'-UTR, which influence the osteoclast differentiation and osteolysis formation. Thus, these results suggest that miR-30a could directly target RunX2 and participate in osteolysis in GCT. (C) 2014 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?